US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
US4804663A
(en)
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
US5576195A
(en)
|
1985-11-01 |
1996-11-19 |
Xoma Corporation |
Vectors with pectate lyase signal sequence
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
DE560410T1
(de)
|
1987-04-27 |
2001-12-20 |
Unilever Nv |
Testgerät zur Durchführung von spezifischen Bindungsprüfungen.
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
DE69232002T2
(de)
|
1991-06-07 |
2002-06-06 |
Johnson & Johnson Clin Diag |
Immunoassays unter Verwendung von markierten Hapten-Analogen
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
PT582368E
(pt)
|
1992-05-29 |
2001-05-31 |
Lilly Co Eli |
Derivados de tienobenzodiazepina para o tratamento de doencas de cns
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
HU219487B
(hu)
|
1993-11-19 |
2001-04-28 |
Janssen Pharmaceutica Nv. |
Riszperidont tartalmazó mikrorészecskék, eljárás előállításukra, alkalmazásuk és ezeket tartalmazó gyógyászati készítmények és előállításuk
|
WO1995034652A1
(fr)
|
1994-06-10 |
1995-12-21 |
Oklahoma Medical Research Foundation |
Anticorps recombine se liant au calcium contre la proteine c
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
WO1998059233A1
(fr)
|
1997-06-23 |
1998-12-30 |
Luminex Corporation |
Lasers entrelaces pour une mesure de fluorescences multiples
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
RU2181297C2
(ru)
|
2000-06-20 |
2002-04-20 |
Эпштейн Олег Ильич |
Способ лечения патологического синдрома и лекарственное средство
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
US7193065B2
(en)
|
2001-07-13 |
2007-03-20 |
Roche Diagnostics Operations, Inc. |
Protease inhibitor conjugates and antibodies useful in immunoassay
|
DE60335428D1
(de)
|
2002-01-31 |
2011-02-03 |
Randox Lab Ltd |
Immunogene, Antikörper und Konjugate für Ketamin und dessen Metaboliten
|
JP2005526501A
(ja)
|
2002-02-21 |
2005-09-08 |
デューク・ユニヴァーシティ |
自己免疫疾患用の試薬および治療方法
|
KR20040088519A
(ko)
|
2002-02-22 |
2004-10-16 |
뉴 리버 파마슈티칼스, 인크. |
활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
|
ES2297142T3
(es)
|
2002-03-28 |
2008-05-01 |
Eli Lilly And Company |
Arilbenzodiazepinas sustituidas con piperazina y su uso como antagonistas del receptor de dopamina para el tratamiento de trastornos psicoticos.
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
CA2494109A1
(fr)
|
2002-07-29 |
2004-02-05 |
Potomac, Pharma, Llc. |
Therapies de combinaison antipsychotiques et compositions d'un antagoniste du recepteur d'alpha-2 adrenergique et d'un tranquillisant majeur antipsychotique atypique
|
DE60313634T2
(de)
|
2002-08-05 |
2008-01-31 |
Eli Lilly And Co., Indianapolis |
Piperazinsubstituierte arylbenzodiazepine
|
US7271252B2
(en)
|
2003-04-22 |
2007-09-18 |
Roche Diagnostics Operations, Inc. |
Reagents for detecting efavirenz
|
EP1626993B1
(fr)
|
2003-05-09 |
2015-03-11 |
Duke University |
Anticorps specifiques de cd20 et leurs methodes d'utilisation
|
BRPI0413555A
(pt)
|
2003-08-18 |
2006-10-17 |
Lundbeck & Co As H |
composto ou sal do mesmo, composição farmacêutica, uso de um composto ou sal, e, método para o tratamento de uma doença, para a fabricação de um composto e para a preparação de composto
|
ES2335589T3
(es)
|
2003-09-23 |
2010-03-30 |
Fermion Oy |
Preparacion de quetiapina.
|
BRPI0415165A
(pt)
|
2003-10-01 |
2007-01-09 |
Adolor Corp |
composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem
|
DK1675573T4
(da)
|
2003-10-23 |
2012-08-06 |
Otsuka Pharma Co Ltd |
Steril, injicerbr aripiprazol-formulering med kontrolleret frigivelse samt fremgangsmåde
|
DE602004024236D1
(en)
|
2003-12-12 |
2009-12-31 |
Inverness Medical Switzerland |
Assay
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
JP4943144B2
(ja)
|
2004-04-26 |
2012-05-30 |
松山 隆美 |
葉酸リセプターベータ(FR−β)に対する単クローン抗体を含有する治療薬
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
US20060235005A1
(en)
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
US20080214808A1
(en)
|
2005-04-25 |
2008-09-04 |
Thomas Frederik Ernestine Spittaels |
Preparation of Aseptic 3-[2-[4-((6-Fluoro-1,2-Benzisoxazol-3-Yl)-1-Piperidinyl]-6,7,8,9-Tetrahydro-9-Hydroxy-2-Methyl-4H-Pyrido[1,2-a]Pyrimidin-4-One Palmitate Ester
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
SE0501418L
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
EP2078731A4
(fr)
|
2006-10-20 |
2012-08-01 |
Forerunner Pharma Res Co Ltd |
Composition pharmaceutique comprenant un anticorps anti-hb-egf comme ingrédient actif
|
JP2010507648A
(ja)
|
2006-10-25 |
2010-03-11 |
ラモット アット テル−アビブ ユニバーシティー リミテッド |
グルタミン酸nmda活性を有する新規向精神薬
|
US20080138842A1
(en)
|
2006-12-11 |
2008-06-12 |
Hans Boehringer |
Indirect lateral flow sandwich assay
|
JP5632582B2
(ja)
|
2006-12-14 |
2014-11-26 |
中外製薬株式会社 |
抗Claudin3モノクローナル抗体およびそれを用いる癌の治療および診断
|
EP2118654B1
(fr)
|
2006-12-29 |
2013-03-27 |
Abbott Laboratories |
Dosage diagnostique pour la detection d'une molecule ou d'un medicament dans du sang total
|
CN101600716A
(zh)
|
2007-01-08 |
2009-12-09 |
阿特维斯集团公司 |
用于制备9-羟基-3-(2-氯乙基)-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮盐酸盐的改进方法
|
CN101245065B
(zh)
|
2007-02-14 |
2010-05-19 |
江苏恩华药业股份有限公司 |
制备苯并异噁唑衍生物的方法及其中间体
|
MX2010003259A
(es)
|
2007-09-27 |
2010-04-12 |
Novartis Ag |
Ensayo de monitoreo de farmacos.
|
EA028427B1
(ru)
|
2008-07-21 |
2017-11-30 |
Пробиодруг Аг |
АНТИТЕЛО, СВЯЗЫВАЮЩЕЕСЯ С Aβ-ПЕПТИДАМИ ИЛИ ИХ ВАРИАНТАМИ, КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЭТО АНТИТЕЛО, И ЕГО ПРИМЕНЕНИЕ
|
MX2011001384A
(es)
|
2008-08-06 |
2011-09-27 |
Gosforth Ct Holdings Pty Ltd |
Composiciones y metodos para tratar trastornos psiquiatricos.
|
US20100069356A1
(en)
|
2008-09-17 |
2010-03-18 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
TW201020258A
(en)
|
2008-10-14 |
2010-06-01 |
Astrazeneca Ab |
Chemical compounds 542
|
CA2742074A1
(fr)
|
2008-10-29 |
2010-08-26 |
Janssen Pharmaceutica Nv |
Procedes de traitement d'une psychose et de la schizophrenie bases sur des polymorphismes du gene erbb4
|
EP2194048A1
(fr)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Esters de nitrate pour le traitement de maladies vasculaires et métaboliques
|
WO2010083843A1
(fr)
|
2009-01-26 |
2010-07-29 |
Egalet A/S |
Formulations à libération contrôlée avec efficacité continue
|
CA2754906C
(fr)
|
2009-03-10 |
2021-02-09 |
Baylor Research Institute |
Antigene presentant des proteines de fusion ciblees sur la cellule renfermant un lien destine a augmenter la stabilite
|
CA2766033C
(fr)
|
2009-06-25 |
2016-09-20 |
Alkermes, Inc. |
Promedicaments de composes nh acides
|
SI2459220T1
(sl)
|
2009-07-31 |
2020-12-31 |
Ascendis Pharma A/S |
Biorazgradljivi v vodi netopni hidrogeli na osnovi polietilenglikola
|
CA2771436A1
(fr)
|
2009-08-17 |
2011-02-24 |
Forerunner Pharma Research Co., Ltd. |
Composition pharmaceutique contenant un anticorps anti-hb-egf comme ingredient actif
|
WO2011042450A1
(fr)
|
2009-10-06 |
2011-04-14 |
Ascendis Pharma As |
Promédicaments à base de palipéridone liée à un support
|
EP2343296A1
(fr)
|
2009-12-01 |
2011-07-13 |
Chemo Ibérica, S.A. |
Procédé pour la purification de la palipéridone
|
AU2010336981B2
(en)
|
2009-12-31 |
2014-04-10 |
Kempharm, Inc. |
Amino acid conjugates of quetiapine, process for making and using the same
|
US20110223207A1
(en)
|
2010-03-11 |
2011-09-15 |
Travis Mickle |
Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same
|
US8114621B2
(en)
|
2010-03-12 |
2012-02-14 |
Saladax Biomedical Inc. |
Lenalidomide and thalidomide immunoassays
|
US8088594B2
(en)
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
WO2011159537A2
(fr)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Procédé et dispositif pour la détection d'analytes
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
AU2011270701B2
(en)
|
2010-06-24 |
2015-05-14 |
Alkermes Pharma Ireland Limited |
Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
US9156822B2
(en)
|
2010-07-02 |
2015-10-13 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine D2 receptors
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
EP2741779A1
(fr)
|
2011-08-12 |
2014-06-18 |
Ascendis Pharma A/S |
Promédicaments liés à des excipients hydrosolubles de forte charge
|
US20140243254A1
(en)
|
2011-08-12 |
2014-08-28 |
Ascendis Pharma A/S |
Polymeric Hyperbranched Carrier-Linked Prodrugs
|
EP2790734B1
(fr)
|
2011-12-15 |
2019-02-20 |
Alkermes Pharma Ireland Limited |
Promédicaments de composés amine secondaires
|
PE20151138A1
(es)
|
2012-08-16 |
2015-08-07 |
Janssen Pharmaceutica Nv |
Pirazoloes sustituidos como bloqueadores del canal de calcio tipo n
|
CN104736565B
(zh)
|
2012-08-21 |
2019-03-12 |
詹森药业有限公司 |
利培酮半抗原的抗体及其用途
|
PT2888258T
(pt)
|
2012-08-21 |
2019-08-21 |
Janssen Pharmaceutica Nv |
Hapteno de paliperidona
|
CN110054694B
(zh)
|
2012-08-21 |
2024-02-20 |
詹森药业有限公司 |
阿立哌唑半抗原的抗体及其用途
|
EP2888590B1
(fr)
|
2012-08-21 |
2020-07-08 |
Janssen Pharmaceutica NV |
Anticorps dirigés contre l'olanzapine et leur utilisation
|
EP3321254B1
(fr)
|
2012-08-21 |
2020-08-12 |
Janssen Pharmaceutica NV |
Haptènes d'aripiprazole et leur utilisation dans des dosages immunologiques
|
EP3492473A1
(fr)
|
2012-08-21 |
2019-06-05 |
Janssen Pharmaceutica NV |
Haptènes d'olanzipine
|
PT3305784T
(pt)
|
2012-08-21 |
2020-10-23 |
Janssen Pharmaceutica Nv |
Haptenos de quetiapina para utilização em ensaios imunológicos
|
ES2904838T3
(es)
|
2012-08-21 |
2022-04-06 |
Janssen Pharmaceutica Nv |
Haptenos de risperidona y paliperidona
|
ES2654413T3
(es)
|
2012-08-21 |
2018-02-13 |
Janssen Pharmaceutica, N.V. |
Anticuerpos a quetiapina y uso de los mismos
|
CN104736561B
(zh)
|
2012-08-21 |
2018-06-12 |
詹森药业有限公司 |
帕潘立酮的抗体及其用途
|
EP2888287A4
(fr)
|
2012-08-21 |
2016-04-20 |
Ortho Clinical Diagnostics Inc |
Anticorps dirigés contre des haptènes de palipéridone et leur utilisation
|
CN109400708A
(zh)
|
2012-08-21 |
2019-03-01 |
詹森药业有限公司 |
奥氮平半抗原的抗体及其用途
|
CA2882562C
(fr)
|
2012-08-21 |
2019-08-27 |
Eric Hryhorenko |
Anticorps diriges contre l'aripiprazole et leur utilisation
|
CN104737017B
(zh)
|
2012-08-21 |
2017-03-08 |
詹森药业有限公司 |
利培酮的抗体及其用途
|
AU2013305904B2
(en)
|
2012-08-21 |
2017-08-17 |
Saladax Biomedical Inc. |
Antibodies to quetiapine haptens and use thereof
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
EP3390455A1
(fr)
|
2015-12-17 |
2018-10-24 |
Janssen Pharmaceutica NV |
Anticorps dirigés contre la quétiapine et utilisation associée
|
US10444250B2
(en)
|
2015-12-17 |
2019-10-15 |
Janssen Pharmaceutica Nv |
Antibodies to risperidone and use thereof
|